HORIZON-HLTH-2021-CORONA-01

Suggested coordinators

Organisations that coordinated the most funded projects under this call.

• CHUV1 coordinated
• EuResist1 coordinated
• EXEVIR BIO1 coordinated
• FABENTECH1 coordinated
• HIPRA SCIENTIFIC1 coordinated
• GUF1 coordinated
• METRIOPHARM AG1 coordinated
• Ecraid1 coordinated

Strong partners

Frequent participants in this call’s funded projects (research, universities, public bodies, and mixed types).

• UNIVERSITY COLLEGE LONDON3 projects · UK
• ICS3 projects · ES
• NORWEGIAN INSTITUTE OF PUBLIC HEALTH NIPH2 projects · NO
• FONDAZIONE PENTA ETS2 projects · IT
• FIB-H12O2 projects · ES
• HOSPITAL CLINIC DE BARCELONA2 projects · ES
• IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2 projects · UK
• INSERM2 projects · FR
• SU UNIVERSITY OF STELLENBOSCH2 projects · ZA
• UMIL2 projects · IT

Industry partners

Companies and SMEs that appear often in this call’s historical projects.

• EXEVIR BIO1 projects · company
• FABENTECH1 projects · sme
• HIPRA SCIENTIFIC1 projects · company
• METRIOPHARM AG1 projects · company
• accelCH1 projects · sme
• ASPHALION1 projects · sme
• PHOX Consulting e.U.1 projects · company
• Catalyze B.V.1 projects · sme
• coneno1 projects · sme
• DRUG DEVELOPMENT AND REGULATION SL1 projects · sme
• F4 Pharma1 projects · company
• GRANZER REGULATORY CONSULTING & SERVICES1 projects · company

Typical consortium size

Derived from historical funded projects linked to this call.

Partners per project

median 17 · avg 15.4

range 4 – 34 organisations

Country spread (sample)

18 countries

15–19 partner organisations (from median 17.0 in this call’s projects) · 18 countries appear often in the participant sample

Similar past projects

Largest EU contributions in this call — useful references for consortium patterns.

• VERDI€15,395,599
• END-VOC€10,496,137
• CoVICIS€10,048,971
• ECRAID-Prime€9,998,518
• EuCARE€9,995,920
• COVend€9,994,978
• XVR011 Phase 2€9,902,750
• RBDCOV€9,779,211
• EPIC-CROWN-2€9,070,134
• iMPact€7,988,724